Physician profile
Martin Frey
NPI 1164424719
$6,229.30
in general payments reported to CMS, 2019-2025
36 companies · $160 in 2025
The $160 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $971 · 2020: $436 · 2021: $1,102 · 2022: $954 · 2023: $1,691 · 2024: $915 · 2025: $160.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,767.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,766.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,142.60 | 2021-2025 | Mycarelink, Micra, Cardioblate Cryoflex |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $600.13 | 2019-2024 | Lifevest |
| Pfizer INC. | $436.18 | 2019-2024 | |
| Medtronic Vascular, INC. | $395.15 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $277.89 | 2019-2023 | Xarelto |
| Boston Scientific Corporation | $262.36 | 2021-2023 | Watchman Flx |
| Philips North America LLC | $212.88 | 2020-2024 | (Ck4) Mcot |
| Astrazeneca Pharmaceuticals LP | $197.64 | 2020-2023 | Wainua, Brilinta, Farxiga |
| Heartflow, INC. | $149.02 | 2023 | Ffrct |
| Shockwave Medical, INC | $147.79 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $130.90 | 2019-2023 | Jardiance |
| Merck Sharp & Dohme LLC | $123.49 | 2022-2024 | Verquvo |
| Abbott Laboratories | $113.89 | 2019-2022 | |
| Impulse Dynamics (USA) INC. | $103.34 | 2021-2023 | Optimizer |
| E.R. Squibb & Sons, L.L.C. | $103.15 | 2021-2024 | Camzyos |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $101.52 | 2019 | |
| Sanara Medtech INC. | $99.54 | 2023 | Celleraterx |
| Alnylam Pharmaceuticals INC. | $97.15 | 2025 | Amvuttra |
| Cook Medical LLC | $71.91 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $55.83 | 2022 | |
| Kestra Medical Technology Services, INC. | $52.93 | 2024 | Assure Wcd |
| Kiniksa Pharmaceuticals International, Plc | $46.17 | 2024 | Arcalyst |
| Vital Connect, INC | $41.79 | 2023-2024 | Vitalpatch Rtm |
| Novartis Pharmaceuticals Corporation | $41.24 | 2021-2023 | |
| Sanofi-Aventis U.S. LLC | $35.72 | 2022 | |
| Lantheus Medical Imaging, INC. | $25.95 | 2021 | |
| Cvrx, INC. | $21.82 | 2023 | Barostim Neo System |
| Amgen INC. | $21.30 | 2023 | Repatha |
| Akcea Therapeutics, INC. | $19.87 | 2020 | |
| Novo Nordisk INC | $18.00 | 2023 | Rybelsus, Ozempic |
| Chiesi USA, INC. | $17.12 | 2021 | |
| Esperion Therapeutics, INC. | $15.12 | 2022 | |
| Bardy Diagnostics, INC. | $15.00 | 2022 | |
| Convatec INC. | $14.21 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $12.45 | 2019 | |
| Surmodics, INC. | $8.25 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Martin Frey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.